SUMMARY Right ventricular failure caused by myocardial infarction may be refractory to treatment designed to support the systemic ventricle. A new type of right ventricular assist device driven by an impeller pump was successfully used for 79 hours after emergency revascularisation after right coronary occlusion. Despite renal failure requiring haemofiltration the patient has now fully recovered.
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Right ventricular failure due to infarction on the diaphragmatic surface is characterised by hypotension, neck vein engorgement, and heart block.'
The addition of clinically significant infarction of the left ventricular free wall and septum may contraindicate any effort to increase the right ventricular preload and may also diminish the effectiveness of pulmonary vasodilators which are the mainstay of treatment when right ventricular failure is caused by pulmonary hypertension. Left ventricular function is also embarrassed by inadequate preload caused by insufficient blood crossing the pulmonary vasculature; if this cannot be improved by standard inotropic and vasodilator methods right ventricular assistance is required to maintain systemic perfusion. Right ventricular bypass should also relieve overdistension of the ventricle thus allowing recovery by promoting coronary blood flow to viable muscle.
We describe the successful use of a simple, cheap, and adaptable right ventricular assist device; it was used to support the failing right ventricle when inotropes, vasodilators, and an intra-aortic balloon pump had failed to maintain adequate circulation and prevent progressive acidosis. There are reports of three survivors in whom the combination of an intra-aortic balloon and a right ventricular assist device was used; but none of them had renal failure.2 4 In the present case renal failure was treated by the addition of a haemofiltration circuit. The right ventricle, apart from its diaphragmatic surface, was then seen to be beating well. The balloon pump was removed two days later.
After insertion of the assist device, renal failure (creatinine clearance 2-4 ml/min) was treated by haemofiltration with a Diafilter-20 (Amicon, Danvers, MA 01923, USA) connected in parallel with the assist device circuit. Urine output (fig 1) improved to over 30 ml/h with creatinine clearance still 2-4 ml/min. Urine osmolality rose from 308 mOsm/l to 387 mOsm/l and creatinine clearance to 16 ml/min by the twelfth day. Creatinine clearance was 48 ml/min by the 25th day and 95 ml/min on the 32nd postoperative day; creatinine clearance had peaked at 590 pmol/l. In sheep and goat preparations pulmonary artery balloon counterpulsation is reported to provide some assistance to forward flow in pulmonary hypertension.5 However, when the balloon is placed in a side arm attached to the pulmonary artery it will directly promote forward flow and this method has been used clinically and experimentally with moderate benefit.6 " This is slight compared with passive flow and markedly inferior to that achieved with a right ventricular pump assist device. 
